| Preferred Name |
Glipalamide |
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C72797 |
| CAS_Registry |
37598-94-0 |
| Chemical_Formula |
C12H15N3O3S |
| code |
C72797 |
| Concept_In_Subset | |
| Contributing_Source |
FDA |
| DEFINITION |
A second-generation sulfonamide derivative with antihyperglycemic activity. Like other sulfonylureas, glipalamide exerts extra-pancreatic activity, such as increased binding of insulin to insulin receptors on adipocytes. |
| FDA_UNII_Code |
W7J490CUHM |
| FULL_SYN |
3-Methyl-N-(4-methylphenyl)sulfonyl-3,4-dihydropyrazole-2-carboxamide SPC-703 4,5-Dihydro-5-methyl-N-((4-methylphenyl)sulfonyl)-1H-pyrazole-1-carboxamide |
| label |
Glipalamide |
| Legacy_Concept_Name |
Glipalamide |
| Preferred_Name |
Glipalamide |
| prefixIRI |
C72797 |
| prefLabel |
Glipalamide |
| Semantic_Type |
Pharmacologic Substance |
| UMLS_CUI |
C0243356 |
| subClassOf |
| Delete | Mapping To | Ontology | Source |
|---|---|---|---|
| http://purl.bioontology.org/ontology/MESH/C009971 | Medical Subject Headings | LOOM |